Overview
News
Salaries
Products
People
Growth
Offices
Financials

Overview

Medasense is transforming the way PAIN is being assessed and treated worldwide. Through our breakthrough NOL® AI technology and sensing platform, we quantify pain response to optimize care and avoid overmedication.

News

Press release PRNewswire 6 years ago
Israeli Pain Monitoring Startup Medasense Raises $18M in Series C Round
/PRNewswire/ -- Medasense Biometrics Ltd., developer of the NOL technology for pain-response monitoring, today announced that it has raised $18M in a series C...
Read more
Report
Press release PRNewswire 7 years ago
Medasense to Provide Pain Index Solution for Treatment of Dementia Patients
/PRNewswire/ -- Medasense Biometrics Ltd. has been awarded a development grant from the Israel Innovation Authority (IIA) to extend the application of its NOL...
Read more
Report
Press release PRNewswire 9 years ago
Medasense Launches New Pain Monitoring Device, PMD200TM Following European CE Approval
/PRNewswire/ -- - New state-of-the-art technology helps clinicians provide personalised pain relief Medasense Biometrics Ltd. announced today that it has...
Read more
Report

Financials

Total raised
$18M
Latest round
Series C
Funding rounds
1
Funding rounds
Round Announced Amount
Series C 2020 $18M Details